In vascular access management, choosing the most appropriate device directly impacts the ability to reduce complications, improve continuity of therapy, and preserve the patient’s venous access.
Between peripheral and central access devices, there is an intermediate area where it is essential to balance stability, duration, and invasiveness. It is within this space that the Mini Midline fits, a solution developed by the Numantec Group to offer an effective alternative to traditional peripheral catheters (IV cannulas) and standard Midline devices.
Mini Midline: An Intermediate Solution Between Peripheral Access and Midline
The Mini Midline is designed to provide greater dwell time and stability compared to short peripheral devices, while maintaining a reduced level of invasiveness.
Thanks to its long cannula design, the device can remain in situ for up to 29 days, reducing the need for frequent replacements and repeated venous access.
This makes it particularly suitable for treatments lasting longer than a few days, but that do not necessarily require central venous access.
Why Choose a Mini Midline
One of the most relevant aspects of the Mini Midline is its ability to address specific clinical needs, improving patient management throughout the entire course of therapy.
Greater Stability Compared to Short Peripheral Catheters
The increased cannula length provides greater device stability, reducing the risk of dislodgement and associated complications.
Reduced Need for Replacement
The ability to keep the device in situ for up to 29 days helps limit repeated insertions, improving patient experience and optimizing healthcare professionals’ workload.
Reduced Invasiveness Compared to Standard Midlines
The Mini Midline represents a less invasive solution than a standard Midline, while still delivering high clinical performance.
Support for High-Pressure Infusions
The device is designed to handle high-pressure infusions, expanding its use across a wide range of clinical settings.
Benefits in Clinical Practice
The Mini Midline is designed to integrate seamlessly into hospital workflows, helping to make vascular access management simpler and more effective.
Key operational benefits include:
- reduced manipulation;
- improved continuity of therapy;
- lower risk of complications associated with frequent replacements;
- enhanced patient comfort.
Selecting the appropriate device from the outset helps avoid changes in strategy during treatment, with a positive impact on clinical outcomes. The Mini Midline offers a balanced combination of stability, dwell time, efficiency, and reduced invasiveness.
Numantec and the Mini Midline
With the introduction of the Mini Midline, Numantec completes its vascular access portfolio, offering solutions that cover a wide range of clinical needs.
The Group’s devices share the same design philosophy and a consistent structure, differing in length and infusion characteristics to adapt to various clinical scenarios and support healthcare professionals in daily practice.
